Pathogenicity determinants of Candida
- PMID: 2259368
- DOI: 10.1111/myc.1990.33.6.265
Pathogenicity determinants of Candida
Abstract
The incidence of infections due to Candida albicans and other related species has increased in recent years. A number of factors have contributed to this, e.g. the use of a wide range of potent antibacterial and immunosuppressive therapeutic agents and the increased incidence of immune-deficiency diseases such as AIDS. Pathogenicity determinants which confer virulence on C. albicans, and other Candida species to a lesser extent, have been reviewed. These include factors related to species and strains, adherence, dimorphism, toxin and enzyme production and cell surface composition. This review clearly shows that C. albicans virulence is a function of a multiplicity of factors working jointly to overcome the host defences. A lack or debility in any of these parameters will reflect negatively on its infectivity and make it difficult for Candida to establish itself, particularly in a healthy individual.
Similar articles
-
Phospholipases of Candida albicans.Mycoses. 2001 Nov;44(9-10):361-7. doi: 10.1046/j.1439-0507.2001.00685.x. Mycoses. 2001. PMID: 11766099 Review.
-
Comparison of pathogenicity of various Candida albicans and C. stellatoidea strains.Biol Pharm Bull. 2007 Oct;30(10):1870-3. doi: 10.1248/bpb.30.1870. Biol Pharm Bull. 2007. PMID: 17917253
-
Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans.FEMS Yeast Res. 2004 Jan;4(4-5):369-76. doi: 10.1016/S1567-1356(03)00240-X. FEMS Yeast Res. 2004. PMID: 14734017 Review.
-
Effect of phenotypic switching on expression of virulence factors by Candida albicans causing candidiasis in diabetic patients.Rev Iberoam Micol. 2009 Sep 30;26(3):202-5. doi: 10.1016/j.riam.2009.03.001. Epub 2009 Jul 18. Rev Iberoam Micol. 2009. PMID: 19635443
-
Pathogenicity and virulence of Candida dubliniensis: comparison with C. albicans.Med Mycol. 2002 Jun;40(3):249-57. doi: 10.1080/mmy.40.3.249.257. Med Mycol. 2002. PMID: 12146754
Cited by
-
A Genome-Scale Metabolic Model for the Human Pathogen Candida Parapsilosis and Early Identification of Putative Novel Antifungal Drug Targets.Genes (Basel). 2022 Feb 5;13(2):303. doi: 10.3390/genes13020303. Genes (Basel). 2022. PMID: 35205348 Free PMC article.
-
Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi.PLoS Pathog. 2014 Mar 13;10(3):e1003996. doi: 10.1371/journal.ppat.1003996. eCollection 2014 Mar. PLoS Pathog. 2014. PMID: 24626467 Free PMC article.
-
Evidence that mannans of Candida albicans are responsible for adherence of yeast forms to spleen and lymph node tissue.Infect Immun. 1993 Jun;61(6):2578-84. doi: 10.1128/iai.61.6.2578-2584.1993. Infect Immun. 1993. PMID: 8500895 Free PMC article.
-
Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013).Geburtshilfe Frauenheilkd. 2015 Apr;75(4):342-354. doi: 10.1055/s-0035-1545741. Geburtshilfe Frauenheilkd. 2015. PMID: 27065484 Free PMC article. No abstract available.
-
Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k).Mycoses. 2021 Jun;64(6):583-602. doi: 10.1111/myc.13248. Epub 2021 Feb 27. Mycoses. 2021. PMID: 33529414 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical